Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Cancer Immunol Immunother. 2018 Jan 13;67(4):639–652. doi: 10.1007/s00262-018-2115-2

Figure 1. Dual conditioning plus TCR-I transfer delays tumor progression and increases the survival of RT4 mice.

Figure 1

a Treatment schema. b Peripheral blood glucose levels of individual mice (black lines). The red line indicates 100 dl/ml (normal). c Kaplan-Meier survival analysis. Median survival (days) is listed beside each group in the key. b,c: N=5–10/group; WBI+αCD40+TCR-I vs. all other treatment groups; **p<0.01 by log rank test in c.